ATE54413T1 - In der dermatologie anwendbare und imidazolidinylurea als aktiven grundbestandteil enthaltende therapeutische zusammensetzung. - Google Patents

In der dermatologie anwendbare und imidazolidinylurea als aktiven grundbestandteil enthaltende therapeutische zusammensetzung.

Info

Publication number: ATE54413T1
Authority: AT; Austria
Prior art keywords: active ingredient; therapeutic composition; imidazolidinylurea; dermatology; main active
Prior art date: 1985-03-26

Application number

AT86470004T

Other languages

English (en)

Inventor

Bensimon Claudine Andermann

Original Assignee

Anben

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-03-26

Filing date

1986-03-24

Publication date

1990-07-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9317667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE54413(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1986-03-24 Application filed by Anben filed Critical Anben

1990-07-15 Application granted granted Critical

1990-07-15 Publication of ATE54413T1 publication Critical patent/ATE54413T1/de

Links

239000004480 active ingredient Substances 0.000 title abstract 2
ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
230000001225 therapeutic effect Effects 0.000 title abstract 2
CVHZOJJKTDOEJC-UHFFFAOYSA-M 1,1-dioxo-1,2-benzothiazol-3-olate Chemical compound C1=CC=C2C([O-])=NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-M 0.000 abstract 1
GAZOQRUEIUBTNF-UHFFFAOYSA-N 1-[4-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-3-[[[4-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]carbamoylamino]methyl]urea Chemical class N1C(=O)NC(=O)C1(CO)NC(=O)NCNC(=O)NC1(CO)NC(=O)NC1=O GAZOQRUEIUBTNF-UHFFFAOYSA-N 0.000 abstract 1
208000002874 Acne Vulgaris Diseases 0.000 abstract 1
238000010521 absorption reaction Methods 0.000 abstract 1
206010000496 acne Diseases 0.000 abstract 1
239000000375 suspending agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Birds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Medicinal Preparation (AREA)

AT86470004T 1985-03-26 1986-03-24 In der dermatologie anwendbare und imidazolidinylurea als aktiven grundbestandteil enthaltende therapeutische zusammensetzung. ATE54413T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR8504616A FR2579463B1 (fr)	1985-03-26	1985-03-26	Composition therapeutique a base d'imidazolidinyluree pour le traitement des manifestations cutanees de l'acne
EP86470004A EP0197876B1 (de)	1985-03-26	1986-03-24	In der Dermatologie anwendbare und Imidazolidinylurea als aktiven Grundbestandteil enthaltende therapeutische Zusammensetzung

Publications (1)

Publication Number	Publication Date
ATE54413T1 true ATE54413T1 (de)	1990-07-15

Family

ID=9317667

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT86470004T ATE54413T1 (de)	1985-03-26	1986-03-24	In der dermatologie anwendbare und imidazolidinylurea als aktiven grundbestandteil enthaltende therapeutische zusammensetzung.

Country Status (5)

Country	Link
EP (1)	EP0197876B1 (de)
AT (1)	ATE54413T1 (de)
DE (1)	DE3672515D1 (de)
FR (1)	FR2579463B1 (de)
IL (1)	IL78269A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2635682A1 (fr) *	1988-08-29	1990-03-02	Anben	Composition cosmetique d'application cutanee pour reduire la sensation de brulure au rasage ou a l'epilation
US5697485A (en)	1995-12-19	1997-12-16	Otis Elevator Company	Passenger conveyor control system having decentralized inputs and outputs
WO2001000158A1 (en) *	1999-06-28	2001-01-04	The Procter & Gamble Company	Cosmetic compositions containing quaternary ammonium compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2108840A (en) *	1981-11-04	1983-05-25	Wigglesworth Ltd	Therapeutic use of imidazolidinyl urea
EP0080281A1 (de) *	1981-11-04	1983-06-01	Wigglesworth Limited	Therapeutische Anwendung von Kondensationsprodukten von Allantoin-Formaldehyd
GB2126089B (en) *	1982-08-06	1985-11-06	Sutton Lab Inc	Composition of matter containing imidazolidinyl urea and parabens
EP0143109A1 (de) *	1983-11-23	1985-06-05	Yoshitomi Pharmaceutical Industries, Ltd.	Gelierte Salbe mit Pranoprofen

1985
- 1985-03-26 FR FR8504616A patent/FR2579463B1/fr not_active Expired
1986
- 1986-03-24 EP EP86470004A patent/EP0197876B1/de not_active Expired - Lifetime
- 1986-03-24 AT AT86470004T patent/ATE54413T1/de not_active IP Right Cessation
- 1986-03-24 DE DE8686470004T patent/DE3672515D1/de not_active Expired - Fee Related
- 1986-03-25 IL IL78269A patent/IL78269A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0197876A1 (de)	1986-10-15
FR2579463A1 (fr)	1986-10-03
DE3672515D1 (de)	1990-08-16
IL78269A (en)	1991-08-16
EP0197876B1 (de)	1990-07-11
FR2579463B1 (fr)	1988-01-29

Similar Documents

Publication	Publication Date	Title
MX9803753A (es)	1998-10-31	Acidos alfa-iminohidroxamicos y -carboxilicos n-sustituidos ciclicos y heterociclicos.
FR2634376B1 (fr)	1992-04-17	Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
DE68912195D1 (de)	1994-02-24	Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
GB8604528D0 (en)	1986-04-03	Therapeutic agents
ATE183075T1 (de)	1999-08-15	Retinoid enthaltendes mittel
ATE161419T1 (de)	1998-01-15	Kosmetische zusammensetzung, die einen lipidstoff und eine hydroxy - oder ketofettsäure enthält
ATE150292T1 (de)	1997-04-15	Titansalz enthaltende, schweisshemmende mittel und zusammensetzung
EP0214254A1 (de)	1987-03-18	Melatoninhaltige mittel sowie deren verwendungen.
ATE52911T1 (de)	1990-06-15	Topische anwendung des 3-phenylacetylamino-2,6piperidindionszur behandlung von hautfalten und hyperpigmentierung.
ATE204455T1 (de)	2001-09-15	Topisches antibakterielles mittel
ITRM910730A1 (it)	1993-03-30	Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
DE59610213D1 (de)	2003-04-17	Gegen Akne und entzündete Comedonen wirksame Wirkstoffkombinationen
ATE54413T1 (de)	1990-07-15	In der dermatologie anwendbare und imidazolidinylurea als aktiven grundbestandteil enthaltende therapeutische zusammensetzung.
ATE81981T1 (de)	1992-11-15	Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe.
DE69024060D1 (de)	1996-01-18	Osteogenesis-stimulierende mittel.
ATE104554T1 (de)	1994-05-15	Topische praeparate.
FI911269A7 (fi)	1991-09-16	Menetelmä ja koostumus aktiivisten aineiden lisääntyneen pitoisuuden aikaansaamiseksi iholla iontoforeesin avulla
DK131586A (da)	1986-03-21	Transdermalt, antiallergisk, farmaceutisk praeparat
DE69018570D1 (de)	1995-05-18	Wasserlösliche Vitamin A-Zubereitungen und deren Verwendung bei der Hautbehandlung.
ATE137955T1 (de)	1996-06-15	Verwendung von 1,2-dipalmitoyl-l-alpha- phosphatidyl-n,n-dimethylethanilamine in dermatologischen und kosmetischen zusammensetzungen
ATE128358T1 (de)	1995-10-15	Therapeutische mittel für diabetisches gangrän.
ATE196599T1 (de)	2000-10-15	Mittel zur topischen anwendung auf der haut zur behandlung und/oder zur verhütung von, durch strahlen verursachten hautschäden
DE3771548D1 (de)	1991-08-29	Verwendung von carbonsaeure in fuer topische anwendung vorgesehenen pharmazeutischen zubereitungen.
DE68906437D1 (de)	1993-06-17	L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.
DE3777411D1 (de)	1992-04-16	Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.

Legal Events

Date	Code	Title	Description
1991-03-15	UEP	Publication of translation of european patent specification
1997-12-15	REN	Ceased due to non-payment of the annual fee